Latest News

Intravenously administered ketamine shown to reduce symptoms of chronic post-traumatic stress disorder

For the first time, evidence that a single dose of IV-administered ketamine was associated with the rapid reduction of symptoms of post-traumatic stress disorder in patients with chronic PTSD was demonstrated in a proof-of-concept, randomized, double blind crossover study. These findings could be the first step toward developing new interventions for PTSD.
View full story

Post your comment.


  • Synapse discovery could lead to new treatments for Alzheimer's disease

  • Structural brain connectivity as a genetic marker for schizophrenia

  • And when the bubbles burst, thunder in neurons

  • Molecular trigger for cerebral cavernous malformation identified

  • Even the elderly can recover from a severe traumatic brain injury

  • White matter damage caused by 'skunk-like' cannabis, study shows

  • Lower availability of omega-3 fatty acids in the body associated with bipolar disorder

  • New protein biomarker identifies damaged brain wiring after concussion

  • Loneliness triggers cellular changes that can cause illness, study shows

  • How cocaine changes the brain